Everfront Biotech Holding Company Limited (EFB)

Everfront Biotech Holding Company will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

EFB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	-1.74	-4.05	0.01
Debt / EBITDA Ratio	-1.20	-1.12	-0.01
Debt / FCF Ratio	-1.35	-1.09	-0.01
Quick Ratio	0.16	0.46	3.14
Return on Equity (ROE)	146.70%	367.14%	-126.92%
Return on Assets (ROA)	-	-111.05%	-110.43%
Return on Capital (ROIC)	-204.00%	-125.15%	-143.33%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).